SciRhom develops multi-target humanized antibodies against iRhom2 to treat autoimmune diseases such as rheumatoid arthritis and inflammatory bowel disease.
Menu
SciRhom develops multi-target humanized antibodies against iRhom2 to treat autoimmune diseases such as rheumatoid arthritis and inflammatory bowel disease.